2 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Active not recruiting 1, Withdrawn 1 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia Nogapendekin alfa inbakicept (NAI), agenT-797 - Community-Acquired Pneumonia (CAP), Acute Respiratory Distress Syndrome (ARDS) | Phase 3 | Withdrawn | ImmunityBio, Inc. | 2026-04-15 | 2026-05-08 | |
| A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome OTL-103 - Wiskott-Aldrich Syndrome | Phase 3 | Active not recruiting | Fondazione Telethon | 10 | 2019-01-21 | 2025-09-29 |
| Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. Gammaplex (Intravenous immunoglobulin) - Primary Immunodeficiency, Common Variable Hypogammaglobulinemia | Phase 3 | Completed | Bio Products Laboratory | 50 | 2006-01-01 | 2013-01-24 |
| Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified, Dextrose, 5% in Water - Immunologic Deficiency Syndrome, Agammaglobulinemia | Phase 3 | Completed | Grifols Therapeutics LLC | 100 | 2002-08-01 | 2009-09-25 |
Wiskott-Aldrich Syndrome (3) · Agammaglobulinemia (2) · Common Variable Immunodeficiency (2) · Primary Immunodeficiency Diseases (2) · Community-Acquired Pneumonia (1) · Critical Illness (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Hypogammaglobulinemia, X-Linked (1) · Immunologic Deficiency Syndromes (1) · Respiratory Distress Syndrome (1) · Sepsis (1) · Severe Combined Immunodeficiency (1)
Cytopenia (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Leukocyte Disorders (4) · Leukopenia (4) · Blood Coagulation Disorders (3) · Blood Coagulation Disorders, Inherited (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Hemorrhagic Disorders (3) · Immunologic Deficiency Syndromes (3) · Blood Protein Disorders (2)
Immunoglobulins, Intravenous (2) · gamma-Globulins (2) · Caprylates (1) · Glucose (1) · Water (1)
Bio Products Laboratory (1) · Fondazione Telethon (1) · Grifols Therapeutics LLC (1) · ImmunityBio, Inc. (1)
United States (3) · Canada (1) · Italy (1)
Erwin Gelfand, MD (1) · Jayson Garmizo (1) · Melvin Berger, MD (1)
PMID 36818468, PMID 38446574, PMID 42777242
2018 (1)